Pathstone Holdings LLC Acquires 800 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Pathstone Holdings LLC raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 3.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,109 shares of the medical device company’s stock after purchasing an additional 800 shares during the quarter. Pathstone Holdings LLC’s holdings in Cooper Companies were worth $2,440,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. Quent Capital LLC increased its holdings in Cooper Companies by 300.0% during the first quarter. Quent Capital LLC now owns 828 shares of the medical device company’s stock worth $84,000 after buying an additional 621 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Cooper Companies by 300.0% in the 1st quarter. Acadian Asset Management LLC now owns 720 shares of the medical device company’s stock worth $73,000 after purchasing an additional 540 shares during the period. O Shaughnessy Asset Management LLC lifted its stake in Cooper Companies by 443.6% in the first quarter. O Shaughnessy Asset Management LLC now owns 4,876 shares of the medical device company’s stock valued at $495,000 after purchasing an additional 3,979 shares during the last quarter. Lazard Asset Management LLC grew its holdings in Cooper Companies by 207.6% during the first quarter. Lazard Asset Management LLC now owns 4,759 shares of the medical device company’s stock valued at $482,000 after purchasing an additional 3,212 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its position in Cooper Companies by 302.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 283,380 shares of the medical device company’s stock worth $28,753,000 after buying an additional 212,908 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Up 1.6 %

COO stock opened at $102.40 on Tuesday. The company’s 50 day moving average is $105.74 and its 200 day moving average is $98.39. The stock has a market cap of $20.39 billion, a price-to-earnings ratio of 57.05, a price-to-earnings-growth ratio of 2.17 and a beta of 0.99. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a 1-year low of $82.21 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same quarter last year, the company posted $0.84 EPS. The business’s quarterly revenue was up 7.8% on a year-over-year basis. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Insider Activity

In related news, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. This trade represents a 24.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Brian G. Andrews sold 24,788 shares of the business’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the sale, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at $700,422.60. This represents a 78.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Wells Fargo & Company increased their price target on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Robert W. Baird lifted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Stifel Nicolaus restated a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Morgan Stanley lifted their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.